☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
SynAct Pharma
SynAct Pharma Reports Additional Results of the P-IIb (EXPAND) Study Supporting the Development of Resomelagonin for Rheumatoid Ar...
February 22, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.